Dietary compounds also target antioxidation through activation of the NRF/KEAP1 signaling pathway with anti-BC effects, and anti-inflammation, through the downregulation of pro-inflammatory interleukins 1/6/8, NF-kB, TNF-α, COX2, and iNOS. The gene discussed is NFKB1; the disease is breast cancer.